The 2014 FRAC Code List© and 2014 FRAC Mode of Action Poster© are now online
The 2014 FRAC Code List© and Mode of Action Poster© were revised to include mandestrobin in C3 (inhibition of complex III cytrochrome bc1 at Qo site), oxathiapiprolin in U15 (inhibition of oxysterol binding protein proposed) and tebufloquin in U16 (inhibition of complex III cytochrome bc1, unknown binding site proposed) and move ametoctradin to C8 (complex III cytochrome bc1 at Qo site stigmatellin binding subsite) based on new binding information.